Home > Articles > Published articles > Characterization of RAN Translation and Antisense Transcription in Primary Cell Cultures of Patients with Myotonic Dystrophy Type 1 |
Date: | 2021 |
Abstract: | Myotonic Dystrophy type 1 (DM1) is a muscular dystrophy with a multi-systemic nature. It was one of the first diseases in which repeat associated non-ATG (RAN) translation was described in 2011, but has not been further explored since. In order to enhance our knowledge of RAN translation in DM1, we decided to study the presence of DM1 antisense (DM1-AS) transcripts (the origin of the polyglutamine (polyGln) RAN protein) using RT-PCR and FISH, and that of RAN translation via immunoblotting and immunofluorescence in distinct DM1 primary cell cultures, e. g. , myoblasts, skin fibroblasts and lymphoblastoids, from ten patients. DM1-AS transcripts were found in all DM1 cells, with a lower expression in patients compared to controls. Antisense RNA foci were found in the nuclei and cytoplasm of a subset of DM1 cells. The polyGln RAN protein was undetectable in all three cell types with both approaches. Immunoblots revealed a 42 kD polyGln containing protein, which was most likely the TATA-box-binding protein. Immunofluorescence revealed a cytoplasmic aggregate, which co-localized with the Golgi apparatus. Taken together, DM1-AS transcript levels were lower in patients compared to controls and a small portion of the transcripts included the expanded repeat. However, RAN translation was not present in patient-derived DM1 cells, or was in undetectable quantities for the available methods. |
Grants: | Ministerio de Economía y Competitividad PI15/01756 Instituto de Salud Carlos III PI18/00713 Ministerio de Economía y Competitividad CD14/00032 Agencia Estatal de Investigación PID2020-118730RB-I00 Ministerio de Economía y Competitividad CM16/00016 Ministerio de Economía y Competitividad CPII16/00004 Instituto de Salud Carlos III PI17/00011 Instituto de Salud Carlos III PI20/00114 |
Rights: | Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. |
Language: | Anglès |
Document: | Article ; recerca ; Versió publicada |
Subject: | Antisense transcription ; Myotonic dystrophies ; Phenotypic modulators ; Primary cell cultures ; RAN translation |
Published in: | Journal of clinical medicine, Vol. 10 (november 2021) , ISSN 2077-0383 |
19 p, 4.3 MB |